bpc 157 fda status 2024 2025 panel narrowly backs unapproved peptide drug touted by Joe Rogan FDA adcomm votes in favor
FDA adcomm votes in favor of lifting restrictions on popular wellness peptide BPC 157 FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline RFK Jr. & claimed regenerative peptides like BPC 157 The Niche Peptide Therapy After the FDA Decision: A Readiness Guide
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20


